Charity Search / NATIONAL IMMUNOTHERAPY CANCER RESEARCH FOUNDATION INC
Medical Research (H30Z) 990 on File

NATIONAL IMMUNOTHERAPY CANCER RESEARCH FOUNDATION INC

EIN: 22-3067246 · FLEMINGTON, NJ 08822-0272 · United States · FY 2024 Data
3 out of 5 44 / 100 Based on 2+ years of filings
Financial strength (30%) 75/100
Reliability (20%) 55/100
Effectiveness (25%) 41/100
Impact (25%) No data yet
Financial data: FY 2024 · Scored 9/13/2026
Claim this Charity
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2024
$390K
Total Revenue
$100K
Total Expenses
$880K
Net Assets
0
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio 55.7%
Fundraising Efficiency 0.0%
Operating Reserve 105.11x
Liability-to-Asset 28.6%
Revenue Diversification 129.2%
Executive Compensation $0
Compared with Peers
FY 2024
Compared with 726 similar organizations (United States, Medical Research, $100K–$1M in expenses), FY 2024.
This organization Middle half of peers (P25–P75) Peer median
Ratio This org Peer median Position (P10 → P90)
Program expense ratio
Program expenses / total expenses · higher is better
55.7% 84.5%
P10P90
Bottom quarter
Admin expense ratio
Management and general / total expenses · lower is better
44.3% 11.4%
P10P90
Bottom quarter
Fundraising expense ratio
Fundraising expenses / total expenses · lower is better
0.0% 0.0%
P10P90
Top quarter
Fundraising efficiency
Fundraising expenses / gross fundraising income · lower is better
0.0% 10.0%
P10P90
Top quarter
Operating reserve
Months of expenses covered by net assets · higher is better
105.1 mo 13.4 mo
P10P90
Top quarter
Liabilities to assets
Total liabilities / total assets · lower is better
28.6% 0.4%
P10P90
Bottom quarter
Revenue concentration
Share of revenue from the largest source · lower is better
129.2% 93.3%
P10P90
Bottom quarter
Revenue growth
Year over year revenue growth
157.8% 9.1%
P10P90
Expense growth
Year over year expense growth
2.5% 8.8%
P10P90
Surplus margin
Surplus as a share of revenue
74.3% 1.8%
P10P90
Financial History
Year Revenue Expenses Net Assets Program % Staff
2024 $390K $100K $880K 55.7% 0
2023 $151K $98K $590K 56.1% 0
2022 $4K $136K $479K 82.3% 0
2021 $6K $78K N/A — 0
Donor Reviews
Write a Review
No reviews yet

Be the first to share your experience with this organization.


Write a Review
Minimum 20 characters
Reviews appear after moderation (usually within 24 hours)
Organization Details
EIN
22-3067246
State
NJ
City
FLEMINGTON
ZIP
08822-0272
Classification
H30Z
Category
Medical Research
Rating
3★
Coverage
A
Last Updated
Aug 2026
Form 990
On File
Is this your organization?

Claim it to manage this profile, add your board, financials and impact metrics, and lift your CharityAI™ rating.

Claim this Charity
Back to Search New Search